GleamWall
中文EN

ELMD Electromed, Inc.

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1488917 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.1%
TTM net income YoY45.5%
TTM EPS YoY45.7%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR54.4%

Margins

Gross margin79.0%
Operating margin19.5%
Net margin15.8%
FCF margin11.5%
EBITDA margin20.6%

Returns

ROE24.5%
ROA20.8%
ROIC (approx.)34.3%
Asset turnover1.32x

Leverage & solvency

Liabilities / assets14.1%
Debt / equity0.00x
Current ratio7.19x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio3.6%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$18.68M$19.42M$18.57M$18.90M$16.89M$17.39M$15.68M$16.25M
Cost of revenue$3.75M$4.13M$3.93M$4.08M$3.69M$3.77M$3.46M$3.63M
Gross profit$14.94M$15.28M$14.64M$14.82M$13.20M$13.62M$12.23M$12.63M
R&D expense$277,000$328,000$361,000$384,000$241,000$302,000$277,000$251,000
SG&A expense$11.17M$11.13M$10.52M$10.81M$10.29M$10.28M$9.81M$9.83M
Operating income$3.49M$3.83M$3.77M$3.62M$2.67M$3.04M$2.14M$2.54M
Pretax income$3.64M$3.96M$3.87M$3.73M$2.80M$3.17M$2.28M$2.69M
Income tax$876,000$560,000$863,000$968,000$668,000$971,000$391,000$726,000
Net income$2.76M$3.40M$3.00M$2.76M$2.14M$2.20M$1.89M$1.97M
EBITDA$3.71M$4.05M$3.98M$3.83M$2.88M$3.42M$2.39M$2.75M
EPS (basic)0.33—0.370.330.26—0.220.23
EPS (diluted)0.32—0.350.320.25—0.210.22
Weighted avg. shares (diluted)8.76M—8.65M8.69M8.68M—8.97M8.95M
Banking
Net interest income———————$152,000
Balance sheet
Cash & equivalents$15.88M$20.45M$16.98M$13.79M$14.11M$15.29M$15.24M$16.23M
Receivables$30.27M$29.80M$28.25M$26.26M$24.76M$24.66M$23.44M$22.77M
Inventory$3.81M$3.68M$3.29M$3.46M$3.77M$3.30M$2.97M$3.08M
Current assets$52.19M$57.37M$50.23M$45.57M$44.56M$45.08M$44.20M$44.19M
PP&E, net$5.17M$5.21M$5.21M$5.22M$4.98M$4.71M$4.81M$5.22M
Intangibles$379,000$379,000$354,000$387,000$389,000$371,000$588,000$609,000
Total assets$61.09M$66.27M$59.47M$54.91M$53.61M$53.80M$52.45M$52.27M
Current liabilities$7.26M$12.22M$10.23M$9.38M$8.76M$10.47M$8.51M$8.67M
Total liabilities$8.62M$12.29M$10.31M$9.47M$8.87M$10.59M$8.51M$8.67M
Shareholders' equity$52.47M$53.98M$49.17M$45.44M$44.74M$43.21M$43.94M$43.60M
Shares outstanding8.24M8.37M8.28M8.28M8.36M8.35M8.51M8.56M
Cash flow statement
Operating cash flow$373,000$2.99M$3.48M$3.03M$169,000$3.86M$2.07M$3.15M
Capital expenditure$165,000$219,000$147,000$634,000$252,000$145,000-$153,000$233,000
Free cash flow$208,000$2.77M$3.33M$2.39M-$83,000$3.71M$2.23M$2.92M
Investing cash flow-$202,000-$223,000-$154,000-$656,000-$267,000-$157,000$146,000-$237,000
Financing cash flow-$4.75M$694,000-$128,000-$2.69M-$1.08M-$3.65M-$3.22M-$543,000
Depreciation & amortization$217,000$226,000$215,000$213,000$214,000$376,000$249,000$212,000
Stock-based compensation$435,000$762,000$846,000$656,000$458,000$650,000$757,000$955,000
Share buybacks$4.33M$0$152,000$2.76M$1.00M$3.67M$1.79M-$22,000

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.